Working with Molecular Genetics Chpt. 3: Isolating and Analyzing Genes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Recombinant DNA and Elements Utilizing Recombinant DNA Such As Plasmids and Viral Vectors, and the Application of Recombinant DNA Techniques in Molecular Biology
Fact Sheet Describing Recombinant DNA and Elements Utilizing Recombinant DNA Such as Plasmids and Viral Vectors, and the Application of Recombinant DNA Techniques in Molecular Biology Compiled and/or written by Amy B. Vento and David R. Gillum Office of Environmental Health and Safety University of New Hampshire June 3, 2002 Introduction Recombinant DNA (rDNA) has various definitions, ranging from very simple to strangely complex. The following are three examples of how recombinant DNA is defined: 1. A DNA molecule containing DNA originating from two or more sources. 2. DNA that has been artificially created. It is DNA from two or more sources that is incorporated into a single recombinant molecule. 3. According to the NIH guidelines, recombinant DNA are molecules constructed outside of living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, or molecules that result from their replication. Description of rDNA Recombinant DNA, also known as in vitro recombination, is a technique involved in creating and purifying desired genes. Molecular cloning (i.e. gene cloning) involves creating recombinant DNA and introducing it into a host cell to be replicated. One of the basic strategies of molecular cloning is to move desired genes from a large, complex genome to a small, simple one. The process of in vitro recombination makes it possible to cut different strands of DNA, in vitro (outside the cell), with a restriction enzyme and join the DNA molecules together via complementary base pairing. Techniques Some of the molecular biology techniques utilized during recombinant DNA include: 1. -
Expression Cloning of a Human Dual-Specificity Phosphatase TOSHIO ISHIBASHI, DONALD P
Proc. Nati. Acad. Sci. USA Vol. 89, pp. 12170-12174, December 1992 Biochemistry Expression cloning of a human dual-specificity phosphatase TOSHIO ISHIBASHI, DONALD P. BOTTARO, ANDREW CHAN, TORU MIKI, AND STUART A. AARONSON* Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892 Communicated by Leon A. Heppel, September 24, 1992 ABSTRACT Using an expression cloning strategy, we iso- substrate specificity for both phosphotyrosine and phospho- lated a cDNA encoding a human protein-tyrosine-phosphatase. serine. Bacteria expressing the kinase domain of the keratinocyte growth factor receptor (bek/fibroblast growth factor receptor 2) were infected with a fibroblast cDNA library in a phanid MATERIALS AND METHODS prokaryotic expression vector and screened with a monoclonal Plamid Construction of bek Kiame. The EcoRI-Sal I anti-phosphotyrosine antibody. Among several clones showing fragment of the mouse keratinocyte growth factor (KGF) decreased anti-phosphotyrosine recognition, one displayed receptor cDNA (15), which includes the kinase and carboxyl- phosphatase activity toward the kinase in vitro. The 4.1- terminal domains (residues 361-707), was ligated to the kilobase cDNA encoded a deduced protein of 185 amino ds EcoRP-Sal I fragment ofthe expression vector pCEV-lacZ to with limited sequence similar to the vaccinia virus phospha- generate the plasmid pCEV-bek (Fig. 1A). pCEV-lacZ is a tase VH1. The puriffied recombinant protein dephosphorlated pUC-based plasmid expression vector that produces a 3-gal several activated growth factor receptors, as well as serine- fusion protein under the control of the lac promoter (see phosphorylated casein, in vitro. Both serine and tyrosine phos- below). -
US5266490.Pdf
||||||||||||I|| US005266490A United States Patent (19) 11 Patent Number: 5,266,490 Davis et al. 45 Date of Patent: Nov.30, 1993 (54) MAMMALIAN EXPRESSION VECTOR Maniatis et al. (1990), Molecular Cloning: A Laboratory Manual, vol. 2, pp. 16.3-16.81. 75 Inventors: Samuel Davis, New York; George D. Martson (1987), DNA Cloning: A Practical Approach, Yancopoulos, Briarcliff Manor, both vol. 3, Chap. 4, pp. 59-88. of N.Y. Mizushima et al. (1990), Nucl. Acids Res. 18 (17): 5322. 73) Assignee: Regeneron Pharmaceuticals, Inc., Sambrook et al. (1988), Focus 10(3): 41-48. Tarrytown, N.Y. Simmons et al. (1988), J. Immunol. 141 (8): 2797-2800. Spector (1985), Genet. Engineering 7: 199-234. (21) Appl. No.: 678,408 Stamenkovic et al. (1988), J. Exp. Med. 167: 1975-1980. (22 Filed: Mar. 28, 1991 Urlaub et al. (1980), Proc. Nat. Acad. Sci USA 77(7): 51) Int. Cl.5...................... C12N 15/79; C12N 15/12; 426-4220. C12N 15/18 Woeltje et al. (1990), J. Biol. Chem. 265 (18): 10720-10725. 52) U.S. C. ................................ 435/320.1; 536/23.4; Wysocki et al. (1978); Proc. Nat. Acad. Sci USA 75(6): 536/23.5; 536/24.1 2844-2848. 58) Field of Search ................. 435/320.1, 69.1, 172.3; Seed, B. (Oct. 1987), Nature, vol. 329, pp. 840-842. 536/27, 24.1, 23.4, 23.5 Yanisch-Perron et al. (1985), Gene, vol. 33, pp. (56) References Cited 103-119. PUBLICATIONS Seed et al. (May, 1987), Proc. Nat. Acad. Sci USA, vol. 84, pp. 3365-3369. -
Cloning of Gene Coding Glyceraldehyde-3-Phosphate Dehydrogenase Using Puc18 Vector
Available online a t www.pelagiaresearchlibrary.com Pelagia Research Library European Journal of Experimental Biology, 2015, 5(3):52-57 ISSN: 2248 –9215 CODEN (USA): EJEBAU Cloning of gene coding glyceraldehyde-3-phosphate dehydrogenase using puc18 vector Manoj Kumar Dooda, Akhilesh Kushwaha *, Aquib Hasan and Manish Kushwaha Institute of Transgene Life Sciences, Lucknow (U.P), India _____________________________________________________________________________________________ ABSTRACT The term recombinant DNA technology, DNA cloning, molecular cloning, or gene cloning all refers to the same process. Gene cloning is a set of experimental methods in molecular biology and useful in many areas of research and for biomedical applications. It is the production of exact copies (clones) of a particular gene or DNA sequence using genetic engineering techniques. cDNA is synthesized by using template RNA isolated from blood sample (human). GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) is one of the most commonly used housekeeping genes used in comparisons of gene expression data. Amplify the gene (GAPDH) using primer forward and reverse with the sequence of 5’-TGATGACATCAAGAAGGTGGTGAA-3’ and 5’-TCCTTGGAGGCCATGTGGGCCAT- 3’.pUC18 high copy cloning vector for replication in E. coli, suitable for “blue-white screening” technique and cleaved with the help of SmaI restriction enzyme. Modern cloning vectors include selectable markers (most frequently antibiotic resistant marker) that allow only cells in which the vector but necessarily the insert has been transfected to grow. Additionally the cloning vectors may contain color selection markers which provide blue/white screening (i.e. alpha complementation) on X- Gal and IPTG containing medium. Keywords: RNA isolation; TRIzol method; Gene cloning; Blue/white screening; Agarose gel electrophoresis. -
The Effect of Increasing Plasmid Size on Transformation Efficiency in Escherichia Coli
Journal of Experimental Microbiology and Immunology (JEMI) Vol. 2:207-223 Copyright April 2002, M&I UBC The Effect of Increasing Plasmid Size on Transformation Efficiency in Escherichia coli VICKY CHAN, LISA F. DREOLINI, KERRY A. FLINTOFF, SONJA J. LLOYD, AND ANDREA A. MATTENLEY Department of Microbiology and Immunology, UBC Based on the observation that the transformation of Escherchia coli was more efficient with pUC19 than with the larger plasmid pBR322, we hypothesized that transformation frequency is somehow affected by size. To test this hypothesis, we attempted to insert a 1.7kb lambda NdeI fragment into pUC19 to generate a plasmid (pHEL) of the same size as pBR322. The two plasmids of equal size were then to be used to transform E. coli in order to compare transformation efficiencies. After two rounds of cloning, we were unable to generate pHEL. In lieu of using pHEL and pBR322, E. coli were transformed with previously prepared plasmids of varying sizes: pUC8 (2.6 kb), pUC8 0-690 (4.3 kb), and pUC8 0-690::pKT210 (16.1 kb). The results of these transformations indicate that increasing plasmid size correlates with a decrease in transformation efficiency. Transformation is an important technique in molecular cloning for transferring genetic material to bacteria. It can be done by either heat shock or electroporation. The former involves the preparation of competent cells, incubation of the cells with DNA at 0oC and the completion of DNA uptake by heat pulse. Competent cells are capable of taking up DNA. They can be prepared by cold treatment with calcium chloride. -
Temporal Proteomic Analysis of HIV Infection Reveals Remodelling of The
1 1 Temporal proteomic analysis of HIV infection reveals 2 remodelling of the host phosphoproteome 3 by lentiviral Vif variants 4 5 Edward JD Greenwood 1,2,*, Nicholas J Matheson1,2,*, Kim Wals1, Dick JH van den Boomen1, 6 Robin Antrobus1, James C Williamson1, Paul J Lehner1,* 7 1. Cambridge Institute for Medical Research, Department of Medicine, University of 8 Cambridge, Cambridge, CB2 0XY, UK. 9 2. These authors contributed equally to this work. 10 *Correspondence: [email protected]; [email protected]; [email protected] 11 12 Abstract 13 Viruses manipulate host factors to enhance their replication and evade cellular restriction. 14 We used multiplex tandem mass tag (TMT)-based whole cell proteomics to perform a 15 comprehensive time course analysis of >6,500 viral and cellular proteins during HIV 16 infection. To enable specific functional predictions, we categorized cellular proteins regulated 17 by HIV according to their patterns of temporal expression. We focussed on proteins depleted 18 with similar kinetics to APOBEC3C, and found the viral accessory protein Vif to be 19 necessary and sufficient for CUL5-dependent proteasomal degradation of all members of the 20 B56 family of regulatory subunits of the key cellular phosphatase PP2A (PPP2R5A-E). 21 Quantitative phosphoproteomic analysis of HIV-infected cells confirmed Vif-dependent 22 hyperphosphorylation of >200 cellular proteins, particularly substrates of the aurora kinases. 23 The ability of Vif to target PPP2R5 subunits is found in primate and non-primate lentiviral 2 24 lineages, and remodeling of the cellular phosphoproteome is therefore a second ancient and 25 conserved Vif function. -
Molecular Cloning: a Laboratory Manual, 4Th Edition
This is a free sample of content from Molecular Cloning: A Laboratory Manual, 4th edition. Click here for more information or to buy the book. VOLUME 1 Molecular Cloning A LABORATORY MANUAL FOURTH EDITION © 2012 by Cold Spring Harbor Laboratory Press This is a free sample of content from Molecular Cloning: A Laboratory Manual, 4th edition. Click here for more information or to buy the book. OTHER TITLES FROM CSHL PRESS LABORATORY MANUALS Antibodies: A Laboratory Manual Imaging: A Laboratory Manual Live Cell Imaging: A Laboratory Manual, 2nd Edition Manipulating the Mouse Embryo: A Laboratory Manual, 3rd Edition RNA: A Laboratory Manual HANDBOOKS Lab Math: A Handbook of Measurements, Calculations, and Other Quantitative Skills for Use at the Bench Lab Ref, Volume 1: A Handbook of Recipes, Reagents, and Other Reference Tools for Use at the Bench Lab Ref, Volume 2: A Handbook of Recipes, Reagents, and Other Reference Tools for Use at the Bench Statistics at the Bench: A Step-by-Step Handbook for Biologists WEBSITES Molecular Cloning, A Laboratory Manual, 4th Edition, www.molecularcloning.org Cold Spring Harbor Protocols, www.cshprotocols.org © 2012 by Cold Spring Harbor Laboratory Press This is a free sample of content from Molecular Cloning: A Laboratory Manual, 4th edition. Click here for more information or to buy the book. VOLUME 1 Molecular Cloning A LABORATORY MANUAL FOURTH EDITION Michael R. Green Howard Hughes Medical Institute Programs in Gene Function and Expression and in Molecular Medicine University of Massachusetts Medical School Joseph Sambrook Peter MacCallum Cancer Centre and the Peter MacCallum Department of Oncology The University of Melbourne, Australia COLD SPRING HARBOR LABORATORY PRESS Cold Spring Harbor, New York † www.cshlpress.org © 2012 by Cold Spring Harbor Laboratory Press This is a free sample of content from Molecular Cloning: A Laboratory Manual, 4th edition. -
Human Intestinal Nutrient Transporters
Gastrointestinal Functions, edited by Edgard E. Delvin and Michael J. Lentze. Nestle Nutrition Workshop Series. Pediatric Program. Vol. 46. Nestec Ltd.. Vevey/Lippincott Williams & Wilkins, Philadelphia © 2001. Human Intestinal Nutrient Transporters Ernest M. Wright Department of Physiology, UCLA School of Medicine, Los Angeles, California, USA Over the past decade, advances in molecular biology have revolutionized studies on intestinal nutrient absorption in humans. Before the advent of molecular biology, the study of nutrient absorption was largely limited to in vivo and in vitro animal model systems. This did result in the classification of the different transport systems involved, and in the development of models for nutrient transport across enterocytes (1). Nutrients are either absorbed passively or actively. Passive transport across the epithelium occurs down the nutrient's concentration gradient by simple or facilitated diffusion. The efficiency of simple diffusion depends on the lipid solubility of the nutrient in the plasma membranes—the higher the molecule's partition coefficient, the higher the rate of diffusion. Facilitated diffusion depends on the presence of simple carriers (uniporters) in the plasma membranes, and the kinetic properties of these uniporters. The rate of facilitated diffusion depends on the density, turnover number, and affinity of the uniporters in the brush border and basolateral membranes. The ' 'active'' transport of nutrients simply means that energy is provided to transport molecules across the gut against their concentration gradient. It is now well recog- nized that active nutrient transport is brought about by Na+ or H+ cotransporters (symporters) that harness the energy stored in ion gradients to drive the uphill trans- port of a solute. -
Genomic/Plasmid Dna and Rna)
NPTEL – Bio Technology – Genetic Engineering & Applications MODULE 4- LECTURE 1 ISOLATION AND PURIFICATION OF NUCLEIC ACIDS (GENOMIC/PLASMID DNA AND RNA) 4-1.1. Introduction Every gene manipulation procedure requires genetic material like DNA and RNA. Nucleic acids occur naturally in association with proteins and lipoprotein organelles. The dissociation of a nucleoprotein into nucleic acid and protein moieties and their subsequent separation, are the essential steps in the isolation of all species of nucleic acids. Isolation of nucleic acids is followed by quantitation of nucleic acids generally done by either spectrophotometric or by using fluorescent dyes to determine the average concentrations and purity of DNA or RNA present in a mixture. Isolating the genetic material (DNA) from cells (bacterial, viral, plant or animal) involves three basic steps- • Rupturing of cell membrane to release the cellular components and DNA • Separation of the nucleic acids from other cellular components • Purification of nucleic acids 4-1.2. Isolation and Purification of Genomic DNA Genomic DNA is found in the nucleus of all living cells with the structure of double- stranded DNA remaining unchanged (helical ribbon). The isolation of genomic DNA differs in animals and plant cells. DNA isolation from plant cells is difficult due to the presence of cell wall, as compared to animal cells. The amount and purity of extracted DNA depends on the nature of the cell. The method of isolation of genomic DNA from a bacterium comprises following steps (Figure 4-1.2.)- 1. Bacterial culture growth and harvest. 2. Cell wall rupture and cell extract preparation. Joint initiative of IITs and IISc – Funded by MHRD Page 1 of 57 NPTEL – Bio Technology – Genetic Engineering & Applications 3. -
Molecular Cloning Plasmid-Based Cloning Vectors
Page: 1 Molecular Cloning A glaring problem in most areas of biochemical research is obtaining sufficient amounts of the substance of interest. For example, a 10 L culture of E. coli grown to its maximum titer will only contain about 7 mg of DNA polymerase I, and many other proteins in much lesser amounts. Furthermore, only rarely can as much as half of any protein originally present in an organism be recovered in pure form. Eucaryotic proteins are even more difficult to obtain because tissue samples are usually only available in small quantities. With regards to the amount of DNA present, the 10 L E. coli culture would contain about 0.1mg of any 1000 bp length chromosomal DNA but its purification in the presence of the rest of the chromosomal DNA would be a very difficult task. These difficulties have been greatly reduced through the development of molecular cloning techniques. These methods, which are also referred to as genetic engineering and recombinant DNA technology, deserve much of the credit for the enormous progress in biochemistry and the dramatic rise of the biotechnology industry. The main idea of molecular cloning is to insert a DNA segment of interest into an autonomously replicating DNA molecule, a so-called cloning vector, so that the DNA segment is replicated with the vector. Cloning such a chimeric vector in a suitable host organism such as E. coli or yeast results in the production of large amounts of the inserted DNA segment. If a cloned gene is flanked by the properly positioned control sequences for RNA and protein synthesis, the host may also produce large quantities of the mRNA and protein specified by that gene. -
Eukaryotic Expression Cloning with an Antimetastatic
[CANCER RESEARCH 59, 3812–3820, August 1, 1999] Eukaryotic Expression Cloning with an Antimetastatic Monoclonal Antibody Identifies a Tetraspanin (PETA-3/CD151) as an Effector of Human Tumor Cell Migration and Metastasis1 Jacqueline E. Testa,2,3 Peter C. Brooks,4 Jian-Min Lin,5 and James P. Quigley3 Department of Pathology, State University of New York at Stony Brook, Stony Brook, New York 11794 ABSTRACT interactions with different matrix proteins. Our efforts to identify novel metastasis-associated antigens have, therefore, focused on the tumor cell A monoclonal antibody (mAb), 50-6, generated by subtractive immuniza- surface. As our model system, we have used a highly metastatic human tion, was found to specifically inhibit in vivo metastasis of a human epider- epidermoid carcinoma cell line, HEp-3, which disseminates to host lung moid carcinoma cell line, HEp-3. The cDNA of the cognate antigen of mAb 50-6 was isolated by a modified eukaryotic expression cloning protocol from tissue. The distinct characteristics and behavior patterns of this tumor cell a HEp-3 library. Sequence analysis identified the antigen as PETA-3/CD151, line have been described by Ossowski in a series of papers published a recently described member of the tetraspanin family of proteins. The cloned between 1980 and 1998 (7–9). These cells are very aggressive and readily antigen was also recognized by a previously described antimetastatic anti- give rise to metastasizing tumors in both the chicken embryo (10–12) and body, mAb 1A5. Inhibition of HEp-3 metastasis by the mAbs could not be in the nude mouse model (13, 14). -
Molecular Cloning and Characterization of the STE7 and Steli Genes of Saccharomyces Cerevisiae DEBORAH T
MOLECULAR AND CELLULAR BIOLOGY, Aug. 1985, p. 1878-1886 Vol. 5, No. 8 0270-7306/85/081878-09$02.00/0 Copyright © 1985, American Society for Microbiology Molecular Cloning and Characterization of the STE7 and STElI Genes of Saccharomyces cerevisiae DEBORAH T. CHALEFFt* AND KELLY TATCHELL Department ofBiology, University ofPennsylvania, Philadelphia, Pennsylvania 19104 Received 31 December 1984/Accepted 30 April 1985 In the yeast Saccharomyces cerevisiae, haploid cells occur in one of the two cell types, a or a. The alele present at the mating type (MAT) locus plays a prominent role in the control of cell type expression. An important consequence of the elaboration of ceUl type is the ability of cells of one mating type to conjugate with ceUs of the opposite mating type, resulting in yet a third cell type, an a/a diploid. Numerous genes that are involved in the expression of cel type and the conjugation process have been identified by standard genetic techniques. Molecular analysis has shown that expression of several of these genes is subject to control on the transcriptional level by the MAT locus. Two genes, STE7 and STEII, are required for mating in both haploid ceUl types; ste7 and stell mutants are sterile. We report here the molecular cloning of STE7 and STEII genes and show that expression of these genes is not regulated transcriptionally by the MAT locus. We also have genetically mapped the STEII gene to chromosome XII, 40 centimorgans from ura4. Haploid cells of the yeast Saccharomyces cerevisiae exist tation of a gene whose expression is not mating-type depen- as one of the two cell types, a or a.